Paolo Tombesi - 27 Jul 2022 Form 4 Insider Report for Turning Point Therapeutics, Inc.

Role
EVP & Chief Financial Officer
Signature
/s/ Brian Sun, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
27 Jul 2022
Net transactions value
-$88,654
Form type
4
Filing time
29 Jul 2022, 16:18:14 UTC
Previous filing
11 Feb 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Sale $88,654 -1,183 -4% $74.94 28,700 27 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on July 26, 2021.